Literature DB >> 16572303

Feasibility of in vivo dual-energy myocardial SPECT for monitoring the distribution of transplanted cells in relation to the infarction site.

Nguyen Tran1, Sylvain Poussier, Philippe R Franken, Fatiha Maskali, Frederique Groubatch, Chris Vanhove, Laurent Antunes, Gilles Karcher, Jean-Pierre Villemot, Pierre-Yves Marie.   

Abstract

PURPOSE: Cell therapy using bone marrow mesenchymal stem cells (BMSCs) shows promise in the treatment of myocardial infarction (MI) but accurate cell delivery within MI areas remains critical. In the present study, we tested the feasibility of in vivo pinhole SPECT imaging for monitoring the sites of intramyocardial implanted BMSCs in relation to targeted MI areas in rats.
METHODS: BMSCs were labelled with (111)In-oxine and injected within the fibrotic areas of 3-month-old MI in ten rats. Two days later, dual (111)In/(99m)Tc-sestamibi pinhole SPECT was recorded for localisation of (111)In-BMSCs on a 15-segment left ventricular (LV) division. Additional (99m)Tc-sestamibi pinhole SPECT had been performed 1 month earlier and on the day before transplantation. In vitro counting on histological sections was used to validate the pinhole SPECT determination of (111)In-BMSC activity within LV segments.
RESULTS: The underperfused MI area (segments with <70% uptake) was stable between the (99m)Tc-sestamibi SPECT study recorded at 1 month (4.6+/-1.9 segments) and at 1 day (4.7+/-2.3 segments) before transplantation. (111)In-BMSCs were detected by dual-energy SPECT in 56 segments: 33 (59%) were underperfused MI segments but 23 (41%) were not (14 adjacent and nine remote segments). Finally, (111)In-labelled BMSCs were not detected in 14 out of the 47 (30%) underperfused MI segments.
CONCLUSION: When BMSCs are injected within MI areas in rats, sites of early cell retention do not always match the targeted MI areas. The dual-energy pinhole SPECT technique may be used for monitoring the sites of early retention of implanted BMSCs and the data obtained may have critical importance when analysing the effects of cardiac cell therapy.

Entities:  

Mesh:

Year:  2006        PMID: 16572303     DOI: 10.1007/s00259-006-0075-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  33 in total

1.  Rapid protyping technology in medicine--basics and applications.

Authors:  R Petzold; H F Zeilhofer; W A Kalender
Journal:  Comput Med Imaging Graph       Date:  1999 Sep-Oct       Impact factor: 4.790

2.  Reconstruction of gated myocardial perfusion SPET incorporating temporal information during iterative reconstruction.

Authors:  Christian Vanhove; Philippe R Franken; Michel Defrise; Frank Deconinck; Axel Bossuyt
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-02-19       Impact factor: 9.236

3.  High-resolution simultaneous imaging of SPECT, PET, and MRI tracers on histologic sections of myocardial infarction.

Authors:  Fatiha Maskali; Sylvain Poussier; Pierre-Yves Marie; Nguyen Tran; Laurent Antunes; Pierre Olivier; François Plenat; Serge Maîtrejean; Faïez Zannad; Gilles Karcher
Journal:  J Nucl Cardiol       Date:  2005 Mar-Apr       Impact factor: 5.952

Review 4.  Infarct sizing by scintigraphic techniques and nuclear magnetic resonance imaging.

Authors:  E E van der Wall; M G Niemeyer; A de Roos; A V Bruschke; E K Pauwels
Journal:  Eur J Nucl Med       Date:  1990

5.  In vivo detection of stem cells grafted in infarcted rat myocardium.

Authors:  Rong Zhou; Daniel H Thomas; Hui Qiao; Harshali S Bal; Seok-Rye Choi; Abass Alavi; Victor A Ferrari; Hank F Kung; Paul D Acton
Journal:  J Nucl Med       Date:  2005-05       Impact factor: 10.057

6.  111In oxine labelled mesenchymal stem cell SPECT after intravenous administration in myocardial infarction.

Authors:  B B Chin; Y Nakamoto; J W M Bulte; M F Pittenger; R Wahl; D L Kraitchman
Journal:  Nucl Med Commun       Date:  2003-11       Impact factor: 1.690

7.  Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction.

Authors:  David F Meoli; Mehran M Sadeghi; Svetlana Krassilnikova; Brian N Bourke; Frank J Giordano; Donald P Dione; Haili Su; D Scott Edwards; Shuang Liu; Thomas D Harris; Joseph A Madri; Barry L Zaret; Albert J Sinusas
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

8.  Reproducibility of left ventricular volume and ejection fraction measurements in rat using pinhole gated SPECT.

Authors:  Christian Vanhove; Tony Lahoutte; Michel Defrise; Axel Bossuyt; Philippe R Franken
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-09-15       Impact factor: 9.236

9.  Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling.

Authors:  Alexandra Aicher; Winfried Brenner; Maaz Zuhayra; Cornel Badorff; Schirin Massoudi; Birgit Assmus; Thomas Eckey; Eberhard Henze; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Circulation       Date:  2003-04-14       Impact factor: 29.690

10.  Bone marrow stromal cells improve cardiac performance in healed infarcted rat hearts.

Authors:  Emerson Lopes Olivares; Vanessa P Ribeiro; João P S Werneck de Castro; Karla C Ribeiro; Elisabete C Mattos; Regina C S Goldenberg; José G Mill; Hans F Dohmann; Ricardo Ribeiro dos Santos; Antonio C Campos de Carvalho; Masako Oya Masuda
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-03-25       Impact factor: 4.733

View more
  8 in total

Review 1.  Monitoring left ventricular function in small animals.

Authors:  Tony Lahoutte
Journal:  J Nucl Cardiol       Date:  2007 May-Jun       Impact factor: 5.952

2.  In Vivo Imaging With Confirmation by Histopathology for Increased Rigor and Reproducibility in Translational Research: A Review of Examples, Options, and Resources.

Authors:  Kathleen Gabrielson; Robert Maronpot; Sébastien Monette; Coraline Mlynarczyk; Yuval Ramot; Abraham Nyska; Polina Sysa-Shah
Journal:  ILAR J       Date:  2018-12-01

3.  Acipimox-enhanced ¹⁸F-fluorodeoxyglucose positron emission tomography for characterizing and predicting early remodeling in the rat infarct model.

Authors:  Mélanie Bousquenaud; Fatiha Maskali; Sylvain Poussier; Pierre-Yves Marie; Henri Boutley; Gilles Karcher; Daniel R Wagner; Yvan Devaux
Journal:  Int J Cardiovasc Imaging       Date:  2011-11-25       Impact factor: 2.357

4.  Re-assessment of chronic radio-induced tissue damage in a rat hindlimb model.

Authors:  Bérengère Phulpin; Gilles Dolivet; Pierre-Yves Marie; Sylvain Poussier; Patrice Gallet; Agnès Leroux; Pierre Graff; Frederique Groubach; Pierre Bravetti; Jean-Louis Merlin; Nguyen Tran
Journal:  Exp Ther Med       Date:  2010-07-01       Impact factor: 2.447

5.  Sustained therapeutic perfusion outside transplanted sites in chronic myocardial infarction after stem cell transplantation.

Authors:  Pablo Maureira; Pierre-Yves Marie; Yihua Liu; Fengxu Yu; Sylvain Poussier; Fatiha Maskali; Frederique Groubatch; Gilles Karcher; Nguyen Tran
Journal:  Int J Cardiovasc Imaging       Date:  2013-02-13       Impact factor: 2.357

6.  Feasibility of treating irradiated bone with intramedullary delivered autologous mesenchymal stem cells.

Authors:  Bérengère Phulpin; Gilles Dolivet; Pierre-Yves Marie; Sylvain Poussier; Sandrine Huger; Pierre Bravetti; Pierre Graff; Jean-Louis Merlin; Nguyen Tran
Journal:  J Biomed Biotechnol       Date:  2011-08-29

7.  Cell tracking and therapy evaluation of bone marrow monocytes and stromal cells using SPECT and CMR in a canine model of myocardial infarction.

Authors:  Gerald Wisenberg; Katie Lekx; Pam Zabel; Huafu Kong; Rupinder Mann; Peter R Zeman; Sudip Datta; Caroline N Culshaw; Peter Merrifield; Yves Bureau; Glenn Wells; Jane Sykes; Frank S Prato
Journal:  J Cardiovasc Magn Reson       Date:  2009-04-27       Impact factor: 5.364

Review 8.  In Vivo Tracking of Cell Therapies for Cardiac Diseases with Nuclear Medicine.

Authors:  Mayra Lorena Moreira; Priscylla da Costa Medeiros; Sergio Augusto Lopes de Souza; Bianca Gutfilen; Paulo Henrique Rosado-de-Castro
Journal:  Stem Cells Int       Date:  2016-01-12       Impact factor: 5.443

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.